The FDA has granted a Type C Meeting to Nutriband for their Aversa fentanyl patch, which aims to revolutionize pain management with its innovative abuse-deterrent technology.
A Yale study reveals how racial and ethnic factors impact access to opioid use disorder treatment in emergency departments, highlighting barriers and solutions.